Latest Insider Transactions at Cv Rx, Inc. (CVRX)
This section provides a real-time view of insider transactions for Cv Rx, Inc. (CVRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVRx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVRx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Joseph P Slattery |
BUY
Open market or private purchase
|
Direct |
3,000
+8.92%
|
$24,000
$8.1 P/Share
|
|
Aug 08
2024
|
Joseph P Slattery |
BUY
Open market or private purchase
|
Direct |
3,000
+9.79%
|
$24,000
$8.24 P/Share
|
|
Aug 06
2024
|
Joseph P Slattery |
BUY
Open market or private purchase
|
Direct |
2,500
+9.21%
|
$22,500
$9.09 P/Share
|
|
Aug 05
2024
|
Kevin Hykes PRES & CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$240,000
$8.36 P/Share
|
|
Mar 25
2024
|
Craig E. Palmer SVP, U.S. SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
934
+24.73%
|
$0
$0.24 P/Share
|
|
Feb 29
2024
|
Johnson & Johnson |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,855
+0.01%
|
$0
$0.94 P/Share
|
|
Feb 23
2024
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Bona fide gift
|
Direct |
1,650
-67.21%
|
-
|
|
Feb 20
2024
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
2,545
-50.9%
|
$53,445
$21.91 P/Share
|
|
Feb 20
2024
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$25,000
$5.14 P/Share
|
|
Feb 16
2024
|
Johnson & Johnson |
SELL
Open market or private sale
|
Indirect |
3,725
-0.09%
|
$93,125
$25.81 P/Share
|
|
Feb 16
2024
|
Johnson & Johnson |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
607,725
+12.9%
|
$0
$0.16 P/Share
|
|
Jan 29
2024
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.6%
|
$0
$0.24 P/Share
|
|
Dec 28
2023
|
Joseph P Slattery |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+2.14%
|
$1,950
$1.41 P/Share
|
|
Dec 14
2023
|
Ali Behbahani |
BUY
Exercise of conversion of derivative security
|
Direct |
316
+50.0%
|
$0
$0.24 P/Share
|
|
Oct 16
2023
|
Liz Galle VP OF GLOBAL CLINICAL RESEARCH |
BUY
Exercise of conversion of derivative security
|
Direct |
778
+50.0%
|
$0
$0.24 P/Share
|
|
Sep 18
2023
|
Jared Oasheim CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,862
+15.31%
|
$11,724
$2.1 P/Share
|
|
Sep 15
2023
|
Johnson & Johnson Innovation Jjdc, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,495,575
-100.0%
|
-
|
|
Aug 03
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
628
-100.0%
|
$11,304
$18.55 P/Share
|
|
Aug 02
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Bona fide gift
|
Direct |
2,000
-76.1%
|
-
|
|
Jul 31
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-29.92%
|
$19,074
$17.49 P/Share
|
|
Jul 31
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
$18,750
$5.14 P/Share
|
|
May 16
2023
|
Craig E. Palmer SVP, U.S. SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
295
+50.0%
|
$0
$0.24 P/Share
|
|
Jan 11
2023
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
7,080
-25.9%
|
-
|
|
Nov 30
2022
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Bona fide gift
|
Direct |
4,400
-100.0%
|
-
|
|
Nov 28
2022
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-28.22%
|
$55,200
$12.19 P/Share
|
|
Nov 28
2022
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
$45,000
$5.14 P/Share
|
|
Jun 02
2022
|
Jared Oasheim CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,633
+21.55%
|
$0
$0.24 P/Share
|
|
Jun 02
2022
|
Jared Oasheim CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,952
+40.42%
|
$0
$0.24 P/Share
|
|
May 24
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
8,070
+0.47%
|
$40,350
$5.05 P/Share
|
|
May 23
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
4,432
+0.26%
|
$22,160
$5.04 P/Share
|
|
May 20
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
13,387
+0.78%
|
$66,935
$5.04 P/Share
|
|
May 19
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
10,976
+0.65%
|
$54,880
$5.04 P/Share
|
|
May 05
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
3,992
+0.24%
|
$23,952
$6.0 P/Share
|
|
May 04
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
25,503
+1.5%
|
$127,515
$5.99 P/Share
|
|
May 03
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
32,809
+1.96%
|
$196,854
$6.0 P/Share
|
|
May 02
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
41,988
+2.54%
|
$209,940
$5.97 P/Share
|
|
Apr 28
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
100
+0.01%
|
$500
$5.97 P/Share
|
|
Apr 25
2022
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,059
+18.14%
|
$0
$0.24 P/Share
|
|
Apr 22
2022
|
John Brintnall CHIEF STRATEGY OFFICER AND SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
11,451
+11.86%
|
$0
$0.24 P/Share
|
|
Feb 28
2022
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
600
+15.0%
|
$5,400
$9.03 P/Share
|
|
Feb 24
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
3,400
+0.22%
|
$27,200
$8.24 P/Share
|
|
Feb 23
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
38,200
+2.38%
|
$305,600
$8.04 P/Share
|
|
Feb 22
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
40,008
+2.55%
|
$280,056
$7.94 P/Share
|
|
Feb 18
2022
|
Kirk G. Nielsen |
BUY
Open market or private purchase
|
Indirect |
26,659
+1.76%
|
$186,613
$7.92 P/Share
|
|
Feb 08
2022
|
Dean Bruhn Ding VP OF REG. AFFAIRS AND QA |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+5.99%
|
$0
$0.24 P/Share
|
|
Feb 03
2022
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,690
+23.24%
|
$0
$0.24 P/Share
|
|
Jan 19
2022
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
10,500
-80.24%
|
-
|
|
Jan 13
2022
|
Joseph P Slattery |
BUY
Exercise of conversion of derivative security
|
Direct |
11,640
+5.56%
|
$0
$0.32 P/Share
|
|
Dec 30
2021
|
John Brintnall CHIEF STRATEGY OFFICER AND SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,550
+19.62%
|
$0
$0.24 P/Share
|
|
Dec 28
2021
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,080
+13.71%
|
$0
$0.24 P/Share
|